These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6468483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
    Larsson H, Mattson H, Sundell G, Carlsson E.
    Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
    [Abstract] [Full Text] [Related]

  • 4. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.
    Howden CW, Forrest JA, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1985 Aug; 20(2):137-9. PubMed ID: 3929808
    [Abstract] [Full Text] [Related]

  • 5. Development of an oral formulation of omeprazole.
    Pilbrant A, Cederberg C.
    Scand J Gastroenterol Suppl; 1985 Aug; 108():113-20. PubMed ID: 3858973
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of omeprazole.
    Wallmark B.
    Scand J Gastroenterol Suppl; 1986 Aug; 118():11-7. PubMed ID: 3014640
    [Abstract] [Full Text] [Related]

  • 7. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW, Forrest JA, Reid JL.
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [Abstract] [Full Text] [Related]

  • 8. Acid inhibitory characteristics of omeprazole in man.
    Cederberg C, Ekenved G, Lind T, Olbe L.
    Scand J Gastroenterol Suppl; 1985 Jul; 108():105-12. PubMed ID: 3858972
    [Abstract] [Full Text] [Related]

  • 9. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP, Tuynman HA, Défize J, Pals G, Frants RR, Straub JP, Meuwissen SG.
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [Abstract] [Full Text] [Related]

  • 10. Effect of omeprazole on gastric acid secretion in man.
    Olbe L, Lind T, Cederberg C, Ekenved G.
    Scand J Gastroenterol Suppl; 1986 Jun; 118():105-7. PubMed ID: 3460164
    [Abstract] [Full Text] [Related]

  • 11. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
    Larson C, Cavuto NJ, Flockhart DA, Weinberg RB.
    Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
    [Abstract] [Full Text] [Related]

  • 12. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P, Seitz HK, Simon B, Dammann HG.
    Arzneimittelforschung; 1983 Mar; 33(12):1685-6. PubMed ID: 6686775
    [Abstract] [Full Text] [Related]

  • 13. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP, Campoli-Richards DM.
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [Abstract] [Full Text] [Related]

  • 14. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
    Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L.
    Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and metabolism of omeprazole in man.
    Regårdh CG.
    Scand J Gastroenterol Suppl; 1986 Apr; 118():99-104. PubMed ID: 3460172
    [Abstract] [Full Text] [Related]

  • 16. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
    Hetzel DJ, Shearman DJ.
    Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
    [Abstract] [Full Text] [Related]

  • 17. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG, Müller P, Seitz HK, Simon B.
    Schweiz Med Wochenschr; 1983 Jun 18; 113(24):895-8. PubMed ID: 6348940
    [Abstract] [Full Text] [Related]

  • 18. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage.
    Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, Louis WJ.
    Gastroenterology; 1985 Jan 18; 88(1 Pt 1):64-9. PubMed ID: 3880557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
    Thomson AB, Kirdeikis P, Lastiwka R, Röhss K, Sinclair P, Olofsson B.
    Can J Gastroenterol; 1997 Jan 18; 11(8):657-60. PubMed ID: 9459044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.